Implications of the U.S. Food and Drug Administration Warning against the Use of Sildenafil for the Treatment of Pediatric Pulmonary Hypertension

Author

ABMAN, Steven H¹ ; KINSELLA, John P¹ ; FEINSTEIN, Jeffrey⁸ ; FINEMAN, Jeffrey⁹ ; RAJ, Usha¹⁰ ; HUMPL, Tilman¹¹ ; ROSENZWEIG, Erika B² ; KRISHNAN, Usha² ; KULIK, Thomas³ ; MULLEN, Mary³ ; WESSEL, David L⁴ ; STEINHORN, Robin⁵ ; ADATIA, Ian⁶ ; HANNA, Brian⁷
[1] Department of Pediatrics, University of Colorado School of Medicine, and Children's Hospital Colorado, Aurora, Colorado, United States
[2] Department of Pediatrics, Columbia University, New York City, New York, United States
[3] Department of Cardiology, Harvard Medical School, Boston Children's Hospital, Boston, Massachusetts, United States
[4] Department of Pediatrics, National Children's Hospital, Washington, DC, United States
[5] Department of Pediatrics, Northwestern University, Chicago, Illinois, United States
[6] Stollery Children's Hospital, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada
[7] Department of Pediatrics, University of Pennsylvania Medical School, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
[8] Department of Pediatrics, Stanford University, Palo Alto, California, United States
[9] Department of Pediatrics, University of California San Francisco, San Francisco, California, United States
[10] Department of Pediatrics, University of Illinois Chicago, Chicago, Illinois, United States
[11] Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Pediatric Pulmonary Hypertension Network (PPHNet)

Source

American journal of respiratory and critical care medicine. 2013, Vol 187, Num 6, pp 572-575, 4 p ; ref : 25 ref

ISSN

1073-449X

Scientific domain

Pneumology

Publisher

American Thoracic Society, New York, NY

Publication country

United States

Document type

Article

Language

English

Author keyword

pediatric pulmonary hypertension pulmonary hypertension therapy sildenafil

Keyword (fr)

Enfant Food and Drug Administration Hypertension artérielle pulmonaire Pédiatrie Réanimation Sildénafil Soin intensif Traitement Utilisation Avertissement Homme Pathologie de l'appareil circulatoire Pathologie de l'appareil respiratoire

Keyword (en)

Child Food and Drug Administration Pulmonary hypertension Pediatrics Resuscitation Sildenafil Intensive care Treatment Use Warning Human Cardiovascular disease Respiratory disease

Keyword (es)

Niño Food and Drug Administration Hipertensión arterial pulmonar Pediatría Reanimación Sildenafilo Cuidado intensivo Tratamiento Uso Hombre Aparato circulatorio patología Aparato respiratorio patología

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11C Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27B Intensive care medicine

Discipline

Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Pulmonology

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

27157310

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS